Mary Yue Wang

机构：Chinese University of Hong Kong · ORCID：0009-0004-9412-5687

发表论文 14 篇 · 总被引 13 次 · h-index 2

代表论文

• Risk of severe infection in patients with non‐alcoholic fatty liver disease: Implication on clinical management (2023 · Liver International · 被引 7)
• Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis” (2024 · Clinical and Molecular Hepatology · 被引 4)
• Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study (2026 · Alimentary Pharmacology & Therapeutics · 被引 2)
• Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment (2026 · Clinical and Molecular Hepatology)
• HbA1c trajectories and the risk of liver-related events in patients with type 2 diabetes mellitus (2026 · Journal of Hepatology)
• IDDF2026-ABS-0168 Optimal glycemic target for clinical outcomes in individuals with type 2 diabetes mellitus with and without cirrhosis (2026)